← ANALYST RATINGS · TIPRANKS

Universal Health (UHS): analyst forecast and price target

$185 −1.21% close 16.10.26 · market cap $11.0B · Healthcare · Medical - Care Facilities SPY 0.01%
Price targets and ratings of

Analyst consensus

Hold

4 Buy9 Hold1 Sell

Ratings of 14 analysts in the last 3 months

12-month forecast

$193+4.3% upside

Based on 14 price targets given in the last 3 months, the average target is $193, the highest $290, the lowest $166. The average is +4.3% from the last price of $185.

$150$200$250Jan 26AprJulOctJan 27AprJulOctHigh$290Average$193Low$166
Highest target $290 Average target $193 Lowest target $166
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $183 Hold −1.1% Reiterated 07.10.26on TipRanks Oct 8 21:45 −1.1%next day +1.1% · 5 days +7.4%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $168 Hold −9.2% Reiterated 07.10.26on TipRanks 04:00 −1.1%next day +1.1% · 5 days +7.4%
John Ransom★★★★★★★★★★#681 · hits 60% · avg +10.2% Raymond James — Hold — Reiterated 28.09.26on TipRanks 09:05 0.0%next day −0.8% · 5 days −2.0%
Whit Mayo★★★★★★★★★★#3228 · hits 49% · avg +3.6% Leerink Partners $198 → $205+3.5% Buy +10.8% Reiterated 18.09.26on TipRanks 04:25 −2.4%next day −2.7% · 5 days 0.0%
Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% Wells Fargo $166 Hold −10.3% Reiterated 08.09.26on TipRanks Sep 9 05:30 +1.9%next day +2.7% · 5 days +4.0%
Benjamin Rossi★★★★★★★★★★#2996 · hits 75% · avg +16.8% J.P. Morgan $200 Hold +8.0% Reiterated 03.09.26on TipRanks Sep 4 08:05 0.0%next day +0.6% · 5 days +4.5%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $290 Buy +56.7% Assigned 31.08.26on TipRanks 07:35 −0.5%next day +1.1% · 5 days +1.2%
Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% Bank of America Securities $162 → $170+4.9% Sell −8.2% Reiterated 10.08.26on TipRanks 05:16 −0.4%next day −2.0% · 5 days −1.2%
Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% Goldman Sachs $242 → $190−21.5% Hold +2.6% Assigned 30.07.26on TipRanks 06:20 −4.6%next day +2.4% · 5 days +0.3%
Craig Hettenbach★★★★★★★★★★#1537 · hits 59% · avg +7.6% Morgan Stanley $212 → $191−9.9% Hold +3.2% Reiterated 29.07.26on TipRanks 07:32 +2.7%next day −4.6% · 5 days −3.4%
Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% Robert W. Baird $204 → $166−18.6% Hold −10.3% Reiterated 29.07.26on TipRanks 06:57 +2.7%next day −4.6% · 5 days −3.4%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $197 Buy +6.4% Assigned 29.07.26on TipRanks 02:46 +2.7%next day −4.6% · 5 days −3.4%
Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% Guggenheim $195 → $189−3.1% Buy +2.1% Reiterated 28.07.26on TipRanks Jul 29 07:38 +4.1%next day +2.7% · 5 days −3.1%
Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% Cantor Fitzgerald $194 Hold +4.8% Reiterated 28.07.26on TipRanks 08:15 +4.1%next day +2.7% · 5 days −3.1%
Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% Mizuho Securities $230 → $200−13.0% Buy +8.0% Reiterated 13.07.26on TipRanks 08:16 −1.0%next day −5.9% · 5 days −0.4%
Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% KeyBanc — Hold — Reiterated 28.10.25on TipRanks 03:20 +2.2%next day +2.7% · 5 days +3.9%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Universal Health

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Whit Mayo★★★★★★★★★★Leerink Partners · #3228
Hits 49%220 of 445 Average return +3.6%
1 year Ann Hynes★★★★★★★★★★Mizuho Securities · #1003
Hits 59%296 of 500 Average return +8.1%
2 years Ann Hynes★★★★★★★★★★Mizuho Securities · #1003
Hits 59%296 of 500 Average return +8.1%

Most profitable

3 months Whit Mayo★★★★★★★★★★Leerink Partners · #3228
Hits 49%220 of 445 Average return +3.6%
1 year Ann Hynes★★★★★★★★★★Mizuho Securities · #1003
Hits 59%296 of 500 Average return +8.1%
2 years Ann Hynes★★★★★★★★★★Mizuho Securities · #1003
Hits 59%296 of 500 Average return +8.1%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $194 at a price of $174 (+11.0%); now: $193 at $185 (+4.3%).

$170$180$190$200Sep 15Oct 1Oct 15Top analysts$201Average target$193Price$185

PriceAverage targetTop analysts’ target

Recommendation trend

0102030117141Oct 2517111Nov15101Dec85Jan 261861Feb2681Mar39102Apr36122May2793Jun25134Jul35124Aug35153Sep2181Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy322332
Buy675551
Hold1291312158
Sell234431

Earnings and sales forecast

Next report: 27.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $5.20 (from $4.35 to $5.76). Last quarter: $5.98.

Sales

Next quarter’s sales estimate — $4.7B (from $4.6B to $4.8B). Last quarter: $4.6B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Universal Health
  • CEO: Marc D. Miller
  • Employees: 101,500
  • Universal Corporate Center, King of Prussia, PA, 19406-0958, US
  • uhs.com

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

Data from the stock’s TipRanks forecast page, read 5 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗